The purpose of this paper is to report on twelve cases of kerato-conjunctivitis sicca treated with cortisone drops, systemic cortisone, or ACTH. The cortisone drops used were a 0-625 per cent. solution of cortisone acetate (Merck) in a buffered base, except where stated otherwise.
*Rceived for publication August 20, 1954. Case Notes Case 1, a female aged 41 years, had had rheumatic fever in childhood with resultant mitral stenosis and aortic regurgitation. She had had rheumatoid arthritis for 28 years, latterly associated with KCS, xerostoma, salivary gland enlargement, and a persistent dry cough with small areas of pulmonary atelectasis and recurrent laryngitis. The ocular symptoms were relieved during a course of oral cortisone in December, 1951. An exacerbation of ocular symptoms occurred in October, 1952, when Schirmer's test gave 5 mm. in both eyes, and vision was 6/60 in the right eye, and 6/18 in the left. She was treated with cortisone drops three times daily and obtained relief within 48 hours. In November, 1952, vision was 6/18 in the right eye and 6/5 in the left. Staining was still present but less marked.
In March, 1953, a course of Acthar gel relieved her arthritic and ocular symptoms. The parotid and submandibular swellings subsided. Schirmer's test was not significantly improved (8 mm. maximum). A relapse occurred on cessation of ACTH therapy (April, 1953) . The subsequent course is shown in Table II . March, 1953, vision was 6/18 in the right eye and 6/60 in the left. She was treated with cortisone drops three times daily, and in April, 1953, vision was 6/6 in the right eye and 6/36 in the left. When treatment was discontinued in July, 1953, she relapsed, but she improved again when treatment was resumed. In November, 1953, while she was still receiving drops, vision was 6/5 in the right eye and 6/9 in the left. Schirmer's test showed 4 mm. in both eyes. The cortisone drops were then withdrawn. The subsequent course is shown in Table III . Schirmer's test gave 3 mm. in the right eye and 5 mm. in the left; vision was 6/24 in the right eye and 6/9 in the left. The ocular symptoms had not been relieved by various eye-drops, but improved after subconjunctival injections of 0-3-ml. 2N per cent. cortisone acetate solution.
In April, 1954, oral cortisone 50 mg. daily caused some relief of the arthritis, but there was an exacerbation of the ocular symptoms which was controlled by cortisone drops. The response to Schirmner's test remained unaltered.
Case 11, a female aged 53 years, had had rheumatoid arthritis for 12 years, and recurrent ocular inflammation and corneal ulceration for 9 years. In May, 1954, KCS was diagnosed and Schirmer's test gave 2 mm. in the right eye and 11 mm. in the left. Vision was 6/5 in the right eye and 6/6 in the'left. Corneal scarring was seen in the left eye. Treatment was begun with hydrocortisone eye-drops 0-625 per cent. four times daily to the left eye and cortisone eye-drops four times daily to the right eye. After 2 weeks, subjective improvement occurred in both eyes, but the ophthalmic appearance were unchanged. Schirmer's test gave zero results in both eyes.
Case 12, a female aged 53 years, had had rheumatoid arthritis for 18 years, and recurrent sore eyes and xerostoma for 6 months. In November, 1953, KCS was diagnosed and Schirmer's test gave 8 mm. in the right eye and 4 mm. in the left. Vision was 6/6 part in both eyes. Cortisone drops were given 3-hourly for 2 days, and then three times daily in both eyes; after 1 week there was considerably subjective improvement, but the vision was unaltered and Schirmer's test still gave 2 mm. in the right eye and 1 mm. in the left.
Results of Treatment (a) Topical Therapy.-Cortisone eye-drops were used in the treatment of twelve patients, of whom eight obtained definite and marked relief of symptoms, three obtained partial relief when the drops were instilled frequently, and one derived no benefit. When cortisone eye-drops were effective, the benefit was usually definite within 4 days of starting treatment. Cessation of therapy usually resulted in prompt relapse, but in two instances (Cases 2 and 9) the patients enjoyed relatively prolonged remissions after cortisone was withdrawn.
Hydrocortisone eye-drops were administered to five patients. In only one instance did the benefit obtained from hydrocortisone significantly exceed that derived from cortisone (Case 1). One patient found both local cortisone and hydrocortisone equally ineffective.
The addition of cortisone eye ointment to local therapy in two cases gave no extra benefit.
(b) Systemic Therapy.-Oral cortisone therapy was given to three patients. In two instances (Cases 1 and 7) it was effective in controlling symptoms, but in one (Case 10) 50 mg. daily did not control the ocular symptoms. One patient (Case 1) also had a course of ACTH with suppression of ocular symptoms. Systemic cortisone and ACTH did not lead to any significant increase in lacrimal secretion.
(c) Sealing Lacrimal Puncta and Canaliculi.-This operation was carried out in five patients, all of whom obtained very marked relief, including one who had completely failed to improve (Case 4) and two patients (Cases 3 and 5) who had improved only slightly with cortisone eye-drops.
Discussion
It has been possible to evaluate critically the results of treatment with local cortisone. Control of observations was possible by observing the response in one eye treated with local cortisone while the other eye remained untreated; and also by using interrupted courses of treatment.
The response to local cortisone therapy (0.625 per cent. solution three times daily) was generally good. For the more severe cases stronger preparations were found to be more effective, and more frequent instillation was required. Hydrocortisone eye-drops did not appear to be any more effective than cortisone, although hydrocortisone is usually considered to be more active locally. The addition of cortisone eye ointment to local therapy did not augment the therapeutic response.
Cortisone and hydrocortisone are presumably effective in local treatment by virtue of their direct anti-inflammatory action on the corneal and conjunctival tissues. Amelioration of symptoms and improvement of vision corresponded with reduction of vascular hyperemia and mucoid exudate.
There was usually a definite decrease in the corneal filaments and staining reaction, but this latter finding was not invariably the rule. Topical therapy did not lead to any increased lacrimal secretion as measured by Schirmer's test.
Five patients, three of whom had obtained only slight benefit from the use of cortisone, all received marked benefit from the sealing of the lacrimal puncta. Increase in the values given by Schirmer's test was sometimes noted, but was not so striking as in the cases recorded by Holm (1949) . It is considered that although sealing the lacrimal puncta is the most effective treatment of severe kerato-conjunctivitis sicca, it may give rise to troublesome epiphora and should therefore be reserved for the more severe or persistent cases who either show an inadequate response to local cortisone therapy or who require prolonged treatment.
Summary
Twelve cases of kerato-conjunctivitis sicca are described. Cortisone eye-drops satisfactorily relieved symptoms in most cases. Hydrocortisone drops did not appear to be more effective, nor did the addition of cortisone eye ointment confer any extra benefit. Systemic cortisone and ACTH therapy were effective, but their use is not warranted in the treatment of this condition.
Sealing the lacrimal canaliculi relieved the more severe cases, and this form of treatment is most valuable in patients who require prolonged topical cortisone or whose response is inadequate.
